The anthocyanin delphinidin 3-rutinoside stimulates glucagon-like peptide-1 secretion in murine GLUTag cell line via the Ca 2+ /calmodulin-dependent kinase II pathway
Oral GLP-1 therapies improve convenience, enhance treatment adherence, and reduce barriers associated with injectable medications
Emerging evidence highlights a range of contributing factors, including reduced mechanical loading, increased bone marrow adiposity, hormonal and endocrine alterations, nutritional deficiencies, and disruptions in energy metabolism
Clinical data shows 50-80% of weight loss returns within 12 months after stopping, but this varies widely based on lifestyle maintenance and individual metabolism
By stimulating GLP-1 receptors, Semaglutide helps reduce appetite and enhances feelings of fullness, while also slowing gastric emptying to prolong the sensation of satiety after eating
Zhou S, Sauv RJ, Mmbaga MT, Frenkel C (2005) Cold-induced antioxidant enzymes changes in Leucanthemum maximum Silver Princess